Proactiveinvestors USA & Canada Cellectar Biosciences https://www.proactiveinvestors.com Proactiveinvestors USA & Canada Cellectar Biosciences RSS feed en Thu, 04 Jun 2020 00:55:32 -0400 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) Cellectar Biosciences' stock flies after its multiple myeloma drug shows promising Phase 1 results https://www.proactiveinvestors.com/companies/news/220350/cellectar-biosciences--stock-flies-after-its-multiple-myeloma-drug-shows-promising-phase-1-results-220350.html Wed, 15 May 2019 16:45:00 -0400 https://www.proactiveinvestors.com/companies/news/220350/cellectar-biosciences--stock-flies-after-its-multiple-myeloma-drug-shows-promising-phase-1-results-220350.html Cellectar Biosciences wins FDA Fast Track designation for multiple myeloma drug https://www.proactiveinvestors.com/companies/news/220236/cellectar-biosciences-wins-fda-fast-track-designation-for-multiple-myeloma-drug-220236.html Tue, 14 May 2019 13:45:00 -0400 https://www.proactiveinvestors.com/companies/news/220236/cellectar-biosciences-wins-fda-fast-track-designation-for-multiple-myeloma-drug-220236.html Cellectar Biosciences soars as it plans to initiate Phase 1 study in pediatric cancer patients after FDA grants exemption https://www.proactiveinvestors.com/companies/news/216774/cellectar-biosciences-soars-as-it-plans-to-initiate-phase-1-study-in-pediatric-cancer-patients-after-fda-grants-exemption-216774.html Tue, 19 Mar 2019 14:54:00 -0400 https://www.proactiveinvestors.com/companies/news/216774/cellectar-biosciences-soars-as-it-plans-to-initiate-phase-1-study-in-pediatric-cancer-patients-after-fda-grants-exemption-216774.html Cellectar Biosciences shares soar after its cancer drug receives Rare Pediatric Disease Designation https://www.proactiveinvestors.com/companies/news/205039/cellectar-biosciences-shares-soar-after-its-cancer-drug-receives-rare-pediatric-disease-designation-205039.html Mon, 17 Sep 2018 13:45:00 -0400 https://www.proactiveinvestors.com/companies/news/205039/cellectar-biosciences-shares-soar-after-its-cancer-drug-receives-rare-pediatric-disease-designation-205039.html Cellectar Biosciences shares rollercoaster after one patient sees a 94% tumor reduction in its mid-stage trial https://www.proactiveinvestors.com/companies/news/200985/cellectar-biosciences-shares-rollercoaster-after-one-patient-sees-a-94-tumor-reduction-in-its-mid-stage-trial-200985.html Tue, 17 Jul 2018 19:44:00 -0400 https://www.proactiveinvestors.com/companies/news/200985/cellectar-biosciences-shares-rollercoaster-after-one-patient-sees-a-94-tumor-reduction-in-its-mid-stage-trial-200985.html Cellectar Biosciences jumps after positive tumor study results https://www.proactiveinvestors.com/companies/news/127168/cellectar-biosciences-jumps-after-positive-tumor-study-results-127168.html Wed, 15 Jun 2016 13:55:00 -0400 https://www.proactiveinvestors.com/companies/news/127168/cellectar-biosciences-jumps-after-positive-tumor-study-results-127168.html Cellectar shares extend last Friday's 400% surge https://www.proactiveinvestors.com/companies/news/126285/cellectar-shares-extend-last-friday-s-400-surge-126285.html Mon, 23 May 2016 19:27:00 -0400 https://www.proactiveinvestors.com/companies/news/126285/cellectar-shares-extend-last-friday-s-400-surge-126285.html